Patient no. | Age (yr) | FEV1 (% predicted) | Atopy |
---|---|---|---|
Phase 1 | |||
11-150 | 27 | 97 | G |
21-150 | 26 | 102 | H,G |
31-150 | 28 | 96 | H,C,G |
41-150 | 32 | 71 | H,C,G |
51-150 | 25 | 98 | C,G |
6 | 23 | 86 | C,H |
7 | 28 | 87 | C,H |
8 | 27 | 70 | H,G |
9 | 22 | 116 | H,G |
101-150 | 32 | 85 | H,C,G |
111-150 | 26 | 85 | G |
121-150 | 35 | 81 | H,C,G |
13 | 19 | 100 | H |
14 | 26 | 81 | H,C,G |
15 | 26 | 92 | H |
Mean | 26 | 90 | |
Range | 19–35 | 70–116 | |
Phase 2 | |||
11-150 | 27 | 97 | G |
21-150 | 26 | 102 | H,G |
31-150 | 28 | 95 | H,C,G |
41-150 | 32 | 92 | H,C,G |
51-150 | 25 | 98 | C,G |
6 | 25 | 99 | H,C |
7 | 22 | 93 | H,C,G |
8 | 26 | 77 | H,C |
9 | 24 | 89 | H |
101-150 | 32 | 91 | H,C,G |
111-150 | 26 | 85 | G |
121-150 | 35 | 88 | H,C,G |
131-151 | 22 | 118 | H,C,G |
Mean | 27 | 94 | |
Range | 22–35 | 77–118 |